The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...
Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...
The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...
A federal court in Pennsylvania granted final approval of a $200 million class-action settlement resolving antitrust claims that generic drug manufacturers conspired to inflate prices. The agreement ...
By Kashish Tandon and Rishika Sadam Jan 23 (Reuters) - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said ...
The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...
FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration ...
3. A drug can pass a lab test for purity but fail to work in the human body (bioequivalence).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results